Chad M. Cohen, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 30,000 shares at $32.63 ($957K) on 2021-05-12, disclosed to the SEC on 2021-05-13.
Open-market sale of $957k ADPT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.81 | 2,969 | $91K | 9.6% |
| 2 | $30.81 | 2,969 | $91K | 9.6% |
| 3 | $31.84 | 7,031 | $224K | 23.4% |
| 4 | $31.84 | 7,031 | $224K | 23.4% |
| 5 | $32.63 | 10,000 | $326K | 34.1% |
| Total | $31.90 avg | 30,000 |
| $957K |
| 100% |
| Filing → |
| ADPT | SELL | 2021-10-07 | $324K | — | Filing → |
| ADPT | SELL | 2021-09-09 | $940K | — | Filing → |
| ADPT | SELL | 2021-08-12 | $804K | — | Filing → |